A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis (clinicaltrials.gov) - Aug 6, 2026 - P3 | N=420 | Not yet recruiting | Sponsor: Daewoong Pharmaceutical Co. LTD.
New P3 trial • Gastrointestinal Disorder
|